EUVIMEDOpdag EUVIMED
VergleichsstudieOpen access · CC BY 4.0

Inequities in access to life-saving cardiac devices for heart failure: a comparative analysis of Chile and Mexico

Fernando Lanas, Marco A Alcocer-Gamba, Carlos A Narváez, Rubén Aguayo, Pablo López, Hugo Verdejo, Judith Riesgo, Federico Levy, Svetlana V Doubova, Ricardo Perez-Cuevas, Claudio Muratore

BMC Cardiovascular Disorders · 2026

DOI: 10.1186/s12872-026-05924-4 ↗

At a glance

Vergleichsstudie in BMC Cardiovascular Disorders, 2026. Written by Fernando Lanas and 10 co-authors. Institution: Servicio de Cardiología, Hospital Dr. Hernán Henríquez Aravena, Región de La Araucanía, Chile. Major MEDLINE topics: Heart Failure, Healthcare Disparities, Defibrillators, Implantable, Health Services Accessibility. Cited 1 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medtronic PLC medical device company.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Heart failure (HF) remains a leading cause of death in Latin America, yet access to cardiac implantable electronic devices (CIEDs) is limited. Chile provides HF treatment through the AUGE/GES (Universal Access with Explicit Guarantees in Health) program, while Mexico’s public sector lacks such mechanisms for people without health insurance. This study aims to identify demographic and clinical factors associated with not receiving ICD or CRT-D among HF patients in Chile and Mexico.

Methods

This secondary analysis of the PLASMA study included 246 HF patients eligible for implantable cardioverter-defibrillators (ICDs) or cardiac resynchronization therapy with defibrillator (CRT-D) based on the 2017 ACC/AHA/HRS criteria. Variables included sociodemographic and clinical factors. We performed the Chi-square test and multivariable logistic regression analysis.

Results

Out of 246 eligible patients, 41.1% ( n = 101) received ICD or CRT-D. The mean age of non-recipients was 64.1 years, compared to 58.5 years for recipients. Device implantation rates were higher in Chile (56%) than in Mexico (21%). Compared to Chile, Mexico had more recipients with NYHA class I (11.4% vs. 50%), even though the 2017 ACC/AHA/HRS criteria recommend ICDs and CRT-Ds mainly for symptomatic NYHA II–III patients, with stricter criteria for NYHA I (such as Left Bundle Branch Block, ≥ 40 days post-myocardial infarction, or QRS ≥ 150 ms with optimal therapy). Notably, Mexican patients had 7.6 times higher odds of not receiving a device compared to Chilean patients (aOR 7.58, 95%CI: 3.21–17.91). Care in public hospitals, older age, and NYHA III–IV were also associated with higher odds of not receiving a device, while ventricular arrhythmia and prior revascularization were associated with a lower likelihood of non-implantation (aOR 0.09, 95%CI: 0.04–0.18, and aOR 0.57, 95%CI: 0.33–0.99, respectively), indicating that these patients were substantially more likely to receive a device. No significant sex-related differences were observed.

Conclusions

There are substantial inequities in access to life-saving cardiac devices between Chile and Mexico: structural and demographic factors, particularly the supply capacity of public hospitals and older age, significantly limit access.

Subjects

MeSH terms (MEDLINE)

Heart FailureHealthcare DisparitiesDefibrillators, ImplantableHealth Services AccessibilityElectric CountershockCardiac Resynchronization TherapyCardiac Resynchronization Therapy DevicesHumansChileMexicoFemaleMaleMiddle AgedAgedTreatment OutcomeRisk FactorsSocioeconomic Disparities in HealthUndertreatment

Author keywords

ACC/AHA clinical guidelineCardiac Implantable Electronic DeviceChileHeart FailureMexicoReduced Ejection Fraction

Authors and institutions

  • Servicio de Cardiología, Hospital Dr. Hernán Henríquez Aravena, Región de La Araucanía, Chile.
  • Dirección general, Centro de Estudios Clínicos de Querétaro S.C., Santiago de Querétaro, México.
  • Servicio de Cardiología, Hospital General ISSSTE Tacuba, Ciudad de México, México.
  • Servicio de Cardiología y Arritmias, Hospital San Juan de Dios, Santiago, Chile.
  • Unidad de Hospitalizados CR Cardiovascular, Hospital Dr. Guillermo Grant Benavente, Ciudad de Concepción, Chile.
  • División de Enfermedades Cardiovasculares - Unidad Coronaria, Pontificia Universidad Católica de Chile, Av. Libertador Bernardo O'Higgins 340, Santiago, 8320091, Chile.

Funding

  • Medtronic PLC medical device company

Cite

APA

Lanas, F., Alcocer-Gamba, M. A., Narváez, C. A., Aguayo, R., López, P., Verdejo, H., Riesgo, J., Levy, F., Doubova, S. V., Perez-Cuevas, R., & Muratore, C. (2026). Inequities in access to life-saving cardiac devices for heart failure: a comparative analysis of Chile and Mexico. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-026-05924-4

Vancouver

Lanas F, Alcocer-Gamba MA, Narváez CA, Aguayo R, López P, Verdejo H, et al. Inequities in access to life-saving cardiac devices for heart failure: a comparative analysis of Chile and Mexico. BMC Cardiovascular Disorders. 2026. doi:10.1186/s12872-026-05924-4

BibTeX
@article{Lanas2026,
  author = {Lanas, Fernando and Alcocer-Gamba, Marco A and Narváez, Carlos A and Aguayo, Rubén and López, Pablo and Verdejo, Hugo and Riesgo, Judith and Levy, Federico and Doubova, Svetlana V and Perez-Cuevas, Ricardo and Muratore, Claudio},
  title = {Inequities in access to life-saving cardiac devices for heart failure: a comparative analysis of Chile and Mexico},
  journal = {BMC Cardiovascular Disorders},
  year = {2026},
  doi = {10.1186/s12872-026-05924-4}
}
Start for free →